In this subtype, hypermethylation of the promoter regions of the MLH1 gene leads to its silencing, the accumulation of DNA mutations, and the expression of neoantigens that contribute to the high immunogenicity of the tumor [159]. Here, MLH1 is linked to neoplasm.